Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination
Open Access
- 17 June 2010
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 3 (5) , 475-486
- https://doi.org/10.1038/mi.2010.31
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Disruption of Tight Junctions by Cellulose Sulfate Facilitates HIV Infection: Model of Microbicide SafetyThe Journal of Infectious Diseases, 2009
- Regulatory T Cells Promote Early Influx of CD8+T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance DisparitiesJournal of Virology, 2009
- Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human PapillomavirusJournal of Virology, 2009
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseNature Medicine, 2008
- Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte ResponsesClinical and Vaccine Immunology, 2008
- Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infectionVirology, 2007
- Prophylactic human papillomavirus vaccinesJournal of Clinical Investigation, 2006
- Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in PrimatesJournal of Virology, 2005
- Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particlesGynecologic Oncology, 2005
- HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodVaccine, 2005